In Case You Missed It: News Roundup for Omnipod® 5 Automated Insulin Delivery (AID) System
At Insulet Corporation, makers of Omnipod®, we were born of innovation and a thirst for finding a better, simpler way. Our goal has been and continues to be to reduce burden and improve outcomes for people with diabetes.
Now, after several years in development, the Omnipod® 5 Automated Insulin Delivery (AID) System has officially been cleared by the Food and Drug Administration (FDA) for individuals ages 6 years and older with type 1 diabetes!
Omnipod 5 is the first tubeless AID system managed through a compatible smartphone1 in the U.S. and the only tubeless AID system that integrates with the Dexcom G6® Continuous Glucose Monitor (CGM) System2 to automatically adjust insulin delivery and manage glucose levels both day and night, helping to protect against highs and lows3. Like Omnipod DASH® it continues to be wearable and waterproof†.
But there’s so much more to know. Check out the press clippings below to learn more about the pivotal trial data, to watch a live interview with our President and CEO Shacey Petrovic and to hear from our Senior Vice President and Medical Director Dr. Trang Ly.
Juicebox // listen
Podcast host Scott Benner has an exclusive interview with President and CEO Shacey Petrovic and Medical Director Dr. Trang Ly to talk in-depth about the Omnipod 5 Automated Insulin Delivery (AID) System.
Nerdabetic // watch
Vlogger Kamil Armacki interviews President and CEO Shacey Petrovic about our founding story, features of Omnipod DASH and the future with the Omnipod 5 Automated Insulin Delivery (AID) System.
Diabetes Connections with Stacey Simms // listen
Podcast host Stacey Simms interviews Senior Vice President & Medical Director Dr. Trang Ly about the features of the Omnipod 5 Automated Insulin Delivery (AID) System and what makes it different from the other hybrid closed loop systems that are already on the market.
AJMC, The American Journal of Managed Care // read
AJMC highlights the pivotal study results and shares an expert Q&A on the Omnipod 5 Automated Insulin Delivery (AID) System with Dr. Amy B. Criego, MD, MS, and Dr. Bruce W. Bode, MD.
Healthline // read
Healthline shares the features of the Omnipod 5 Automated Insulin Delivery (AID) System, reviews the pivotal trial data and talks about its anticipated release.
Business Wire // read
BusinessWire gets into specifics of the Omnipod 5 Automated Insulin Delivery (AID) System pivotal study extension data and how it has shown significant improvements in glycemic control with one year of use.
Beyond Type 1 // read
Beyond Type 1 shares a summary of the highlights from the Omnipod 5 Automated Insulin Delivery (AID) System pivotal trial data published by the American Diabetes Association (ADA) Diabetes Care journal.
diatribe // read
diatribe reviews the Omnipod® 5 Automated Insulin Delivery (AID) System clinical trial results, calling them impressive following the European Association for the Study of Diabetes (EASD) 2021 conference.
__________
Don’t wait to experience Pod therapy. Get started on Omnipod DASH® today with a 30-day free trial*.